title: Cingulate cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia.
abstract: The neuronal organization and patterns of afferent innervation are abnormal in the cingulate cortex in schizophrenia, and associated changes in synaptic terminals could be present. A panel of monoclonal antibodies was defined with biochemical and fusion protein studies as detecting syntaxin (antibody SP6), synaptophysin (antibody SP4) and synaptosomal-associated protein-25 (antibody SP12). These antibodies and a polyclonal antibody reactive with neural cell adhesion molecule were used to investigate the cingulate cortex in schizophrenia. Immunocytochemistry indicated that syntaxin immunoreactivity had a considerably wider distribution than synaptophysin. Overall, multivariate analysis indicated increased synaptic terminal protein immunoreactivity in schizophrenia compared to controls (P=0.004). Controlled for age and post mortem interval, syntaxin immunoreactivity was significantly elevated in schizophrenia (P=0.004), and neural cell adhesion molecule immunoreactivity was also elevated (P=0.05). The neural cell adhesion molecule to synaptophysin ratio was increased (P=0.005), possibly indicating the presence of less mature synapses in schizophrenia. Elevated syntaxin immunoreactivity is consistent with increased glutamatergic afferents to the cingulate cortex in schizophrenia, and combined with the neural cell adhesion molecule to synaptophysin ratio results suggests that synaptic function in this region in schizophrenia may be abnormal.
authors.affiliation: Department of Psychiatry, University of British Columbia, Vancouver, Canada.
authors.forename: W G
authors.initials: WG
authors.lastname: Honer
authors.forename: P
authors.initials: P
authors.lastname: Falkai
authors.forename: C
authors.initials: C
authors.lastname: Young
authors.forename: T
authors.initials: T
authors.lastname: Wang
authors.forename: J
authors.initials: J
authors.lastname: Xie
authors.forename: J
authors.initials: J
authors.lastname: Bonner
authors.forename: L
authors.initials: L
authors.lastname: Hu
authors.forename: G L
authors.initials: GL
authors.lastname: Boulianne
authors.forename: Z
authors.initials: Z
authors.lastname: Luo
authors.forename: W S
authors.initials: WS
authors.lastname: Trimble
mesh_terms: D000941:Antigens / Q000276:immunology / Q000378:metabolism; D002540:Cerebral Cortex / Q000378:metabolism*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D015151:Immunoblotting; D007150:Immunohistochemistry; D008297:Male; D008565:Membrane Proteins / Q000378:metabolism; D008875:Middle Aged; D009419:Nerve Tissue Proteins / Q000378:metabolism*; D019006:Neural Cell Adhesion Molecules / Q000378:metabolism*; D017729:Presynaptic Terminals / Q000378:metabolism*; D050765:Qa-SNARE Proteins; D011993:Recombinant Fusion Proteins / Q000737:chemistry / Q000378:metabolism; D012559:Schizophrenia / Q000378:metabolism*; D016708:Synaptophysin / Q000378:metabolism; D050825:Synaptosomal-Associated Protein 25
chemical_list: D000941:Antigens; D008565:Membrane Proteins; D009419:Nerve Tissue Proteins; D019006:Neural Cell Adhesion Molecules; D050765:Qa-SNARE Proteins; D011993:Recombinant Fusion Proteins; C494208:SNAP25 protein, human; D016708:Synaptophysin; D050825:Synaptosomal-Associated Protein 25